PHARMACY

Neose to sell two compounds to Novo Nordisk, BioGenerix

BY Alaric DeArment

PHILADELPHIA Neose Technologies will sell the rights to compounds it had developed with two European companies as its stock trades for just over 20 cents.

The biotech, based in Horsham, Pa., will sell the compounds to Danish drug maker Novo Nordisk and German biotech BioGenerix, with which it had deals to develop the compounds for treating the immune disorder neutropenia and for inhibiting bleeding.

The company was founded in 1990 and went public in 2000.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Save Mart guarantees prescription filling in 19 minutes or less

BY Adam Kraemer

MODESTO, Calif. In an effort to provide faster service, Save Mart Supermarkets has announced that its Save Mart and Lucky banners will guarantee an order of up to three prescriptions filled within 19 minutes.

Customers whose prescriptions take longer than 19 minutes to fill will receive Save Mart’s offer of dinner and a movie: a $10 store gift card and a free one-night rental from redbox. “Every pharmacy needs to fill every prescription accurately,” said Michele Snider, senior director of pharmacy at Save Mart Supermarkets. “Our pharmacies already provide excellent customer service, and now our 19-Minute Promise will ensure that we also deliver prescriptions quickly.”

Save Mart Supermarkets operates 116 pharmacies in 250 stores in Northern California and Northern Nevada.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Study finds home delivery of prescriptions increases generics sales

BY Alaric DeArment

NEW YORK Patients are more likely to use generic drugs if they get them from home delivery pharmacies rather than retail pharmacies, according to a study by pharmacy benefit manager Express Scripts, which operates a home delivery service.

The study found that patients using Sanofi-Aventis’ Ambien (zolpidem) or a generic version of the drug were 34 percent more likely to pick the generic version if they received it by home delivery.

“Financial incentives are important but not enough to realize the full money-saving potential of therapeutically equivalent generics,” study author Emily Cox said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?